DURING THE PAST SEVERAL YEARS, MEASUREMENT OF CREATINE KINASE-MB ISOENZYME (CK-MB) IN SERUM HAS BECOME A VERY POPULAR ASSAY TO DISTINGUISH BETWEEN PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONS (AMI) AND THOSE WITH CHEST PAINS OF OTHER ETIOLOGY.

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$50,000.00
Award Year:
1985
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Award Id:
3233
Agency Tracking Number:
3233
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
100 E. Nasa Road 1, Webster, TX, 77598
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
AMAL MUKHERJEE
PRINCIPAL INVESTIGATOR
(713) 332-9678
Business Contact:
() -
Research Institute:
n/a
Abstract
DURING THE PAST SEVERAL YEARS, MEASUREMENT OF CREATINE KINASE-MB ISOENZYME (CK-MB) IN SERUM HAS BECOME A VERY POPULAR ASSAY TO DISTINGUISH BETWEEN PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONS (AMI) AND THOSE WITH CHEST PAINS OF OTHER ETIOLOGY. CK EXISTS PRIMARILY AS THREE ISOENZYMES: BB, WHICH IS PRESENT IN BRAIN; MB, WHICH PRIMARILY EXISTS IN HEART MUSCLE; AND MM, WHICH IS PRESENT BOTH IN HEART AND SKELETAL MUSCLES. CURRENT METHODS FOR MEASURING MB INCLUDE ELECTROPHORESIS, COLUMN CHROMATOGRAPHY, ENZYME INHIBITION, AND RADIOIMMUNOSSAY (RIA). ALTHOUGH THE ABOVE METHODS ARE USEFUL IN MEASURING MB IN SERUM, THERE ARE INHERENT LIMITATIONS IN THESE METHODS. ELECTROPHORESIS AND CHROMATOGRAPHY ARE NOT SENSITIVE, AND THUS PRECISE QUANTITATION OF MB AT THE LOWER LEVEL BECOMES DIFFICULT. ENZYME INHIBITION AND RIA METHODS, ALTHOUGH QUITE SENSITIVE, MAY NOT BE SPECIFIC ALL THE TIME BECAUSE THEY MEASURE B SUBUNIT OF BOTH MB AND BB AND ALSO CROSS-REACT WITH THE MACROMOLECULAR FORMS OF CK. THREE COMMERCIAL KITS ARE AVAILABLE WHICH MEASURE SPECIFIC MB ISOENZYME: TWO USE SOLID-PHASE SANDWICH IMMUNOASSAY TECHNIQUE AND THE OTHER USES A COMBINATION OF ENZYME INHIBITION AND PRECIPITATION METHODS. STABILITY OF THE COMPONENTS, CUMBERSOME METHODOLOGY, AND POOR SENSITIVITY POSE PROBLEMS IN THE FIRST METHOD; AND THE SECOND IS A VERY TIME-CONSUMING MANUAL METHOD WHOSE COMPLETE AUTOMATION IS DIFFICULT. FOR THESE REASONS DSL, IN COLLABORATION WITH THE UTHSC AT DALLAS, WILL DEVELOP AN ASSAY WHICH WILL SPECIFICALLY MEASURE CK-MB IN SERUM WITHOUT CROSS-REACTIVITY TO OTHER FORMS OF CK. THE PROPOSED METHOD IS TO PREPARE A MONOCLONAL ANTIBODY USING HYBRID CELL TECHNIQUES TO THE CHEMICALLY WELL-DEFINED PURE PROTEIN ANTIGEN, HUMAN HEART (H)CK-MB. SUCH MONOCLONAL ANTIBODY SHOULD BE MONOSPECIFIC IN TERMS OF BINDING TO A UNIQUE DETERMINANT ON THE IMMUNOGEN MOLECULE, CK-MB, AND NOT BE REACTIVE WITH OTHER FORMS OF CK. THIS ANTIBODY WILL THEN BE USED TO DEVELOP A SIMPLE IMMUNOASSAY TO MEASURE SPECIFICALLY CK-MB IN SERUM.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government